Loading stock data…
U.S. Physical Therapy (USPH)
$74.58+1.61 (+2.21%)
Market ClosedLast close Jul 24
U.S.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
U.S. Physical Therapy, Inc. in the Healthcare sector is trading at $74.58 with a market capitalization of $1.0B. Wall Street consensus targets $93.67 (6 analysts), implying a +25.6% move over the next 12 months. The stock is currently 20% below its 52-week high of $93.50, remaining 1.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +25.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $198.29M↓ | $202.73M↑ | $197.13M↓ | $197.34M↑ | $183.79M |
| Gross Profit | $32.75M↓ | $40.13M↑ | $36.87M↓ | $41.62M↑ | $31.07M |
| Operating Income | $14.48M↓ | $22.01M↑ | $19.46M↓ | $24.15M↑ | $14.82M |
| Net Income | -$4.33M↑ | -$10.55M↓ | $5.22M↓ | $7.59M↓ | $12.80M |
Peer Comparison
JNJUNHPFE
Fundamentals
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.82%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.44%
Volume
Today's trading volume
151,156
Recent News
1 Profitable Stock Worth Your Attention and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH)
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at U.S. Physical Therapy (NYSE:USPH) and its peers.
How U.S. Physical Therapy’s (USPH) Clinic Acquisition Supports Its Outpatient Care Roll-Up Strategy
U.S. Physical Therapy, Inc. (NYSE:USPH) is one of the best medical care facilities stocks to buy according to analysts. Analysts see about 29.5% average upside, and the company also has one of the cleaner facility-style profiles in the group because its business is built around outpatient therapy clinics. On July 2, U.S. Physical Therapy announced […]
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?
Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.